http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#Head http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#assertion http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#provenance http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#pubinfo http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#assertion http://purl.obolibrary.org/obo/DOID_1826 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_1826 http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00313 http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association http://www.w3.org/2000/01/rdf-schema#label 1 1 mania divalproex sodium delayed release tablets are a valproate and are indicated for the treatment of the manic episodes associated with bipolar disorder a manic episode is a distinct period of abnormally and persistently elevated expansive or irritable mood typical symptoms of mania include pressure of speech motor hyperactivity reduced need for sleep flight of ideas grandiosity poor judgment aggressiveness and possible hostility the efficacy of divalproex sodium delayed release tablets were established in 3 week trials with patients meeting dsm iii r criteria for bipolar disorder who were hospitalized for acute mania see clinical studies 14 1 the safety and effectiveness of divalproex sodium delayed release tablets for long term use in mania i e more than 3 weeks has not been demonstrated in controlled clinical trials therefore healthcare providers who elect to use divalproex sodium delayed release tablets for extended periods should continually reevaluate the long term usefulness of the drug for the individual patient 1 2 epilepsy divalproex sodium delayed release tablets are indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures divalproex sodium delayed release tablets are also indicated for use as sole and adjunctive therapy in the treatment of simple and complex absence seizures and adjunctively in patients with multiple seizure types that include absence seizures simple absence is defined as very brief clouding of the sensorium or loss of consciousness accompanied by certain generalized epileptic discharges without other detectable clinical signs complex absence is the term used when other signs are also present 1 3 migraine divalproex sodium delayed release tablets are indicated for prophylaxis of migraine headaches there is no evidence that divalproex sodium delayed release tablets are useful in the acute treatment of migraine headaches 1 4 important limitations because of the risk to the fetus of decreased iq neural tube defects and other major congenital malformations which may occur very early in pregnancy valproate should not be administered to a woman of childbearing potential unless the drug is essential to the management of her medical condition see warnings and precautions 5 2 5 3 5 4 8 1 17 3 divalproex sodium delayed release tablets are contraindicated for prophylaxis of migraine headaches in women who are pregnant http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00313 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#provenance http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#pubinfo http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#sig http://purl.org/nanopub/x/hasSignature RdoQbmO0MiZpn7SzmxfqboxMQybMA7YbsmGYDlWy3aqmlNAAsnCBzd5/m7SW8uOa353RgVHaH4OSCjDARZgCBQFNJfGRhqGGvT0X5SaOm7Tk7RGwMNitOzExNkHT6Eh8c0fN0M9WJza7sj/V4XEeDMWjKlHTSNpZz4XdHUQCpPU= http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk http://purl.org/dc/terms/created 2021-06-30T08:53:54.519+02:00 http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA1s3vd-ajOsAfUSOVLsYJZl4XTSBnnD-TDMsnqUG4_vk https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs